Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pollocksville, NC
NPI
1023309325
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
137 Medical Ln
Pollocksville, NC, 28573
Phone (252) 633-1010
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
7,118 services
Medicare patients, 2024
469
Average age 72
Drug cost, 2024
$4.5M
6,131 prescriptions
Company payments, 2025
$1,456
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelsey J Barr was code 99214 (office e&m - established), 657 times for 394 patients. In total Kelsey J Barr billed 7,118 services in 61 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 657 | 394 | $82.74 | $54K |
| 36415 Venipuncture Blood Collection | Office | 564 | 368 | $8.62 | $4,861 |
| 80053 Clinical Chemistry | Office | 512 | 382 | $10.32 | $5,283 |
| 84443 Clinical Chemistry | Office | 504 | 347 | $16.46 | $8,296 |
| 83036 Blood Count | Office | 497 | 314 | $9.48 | $4,709 |
| 82962 Clinical Chemistry | Office | 447 | 243 | $3.20 | $1,430 |
| 84439 Clinical Chemistry | Office | 356 | 223 | $8.79 | $3,131 |
| 85025 Blood Count | Office | 330 | 281 | $7.59 | $2,505 |
| 82043 Clinical Chemistry | Office | 291 | 235 | $5.63 | $1,639 |
| 82570 Clinical Chemistry | Office | 273 | 226 | $5.05 | $1,380 |
| 83721 Clinical Chemistry | Office | 248 | 215 | $10.25 | $2,543 |
| 95251 Test - Miscellaneous | Office | 164 | 74 | $24.99 | $4,098 |
| 96372 Injection Administration | Office | 83 | 21 | $9.14 | $759 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 70 | 17 | $0.82 | $57.24 |
| 82306 Clinical Chemistry | Office | 58 | 44 | $29.01 | $1,683 |
By year: 2022 $149K for 6,174 services; 2023 $125K for 6,105 services; 2024 $115K for 7,118 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 564 | 368 | $8.62 | $4,861 |
| 80053 Clinical Chemistry | 512 | 382 | $10.32 | $5,283 |
| 84443 Clinical Chemistry | 504 | 347 | $16.46 | $8,296 |
| 83036 Blood Count | 497 | 314 | $9.48 | $4,709 |
| 82962 Clinical Chemistry | 447 | 243 | $3.20 | $1,430 |
| 84439 Clinical Chemistry | 356 | 223 | $8.79 | $3,131 |
| 85025 Blood Count | 330 | 281 | $7.59 | $2,505 |
| 82043 Clinical Chemistry | 291 | 235 | $5.63 | $1,639 |
| 82570 Clinical Chemistry | 273 | 226 | $5.05 | $1,380 |
| 83721 Clinical Chemistry | 248 | 215 | $10.25 | $2,543 |
Medicare prescription drug claims, 2024
In 2024, the drug Kelsey J Barr prescribed most often to Medicare patients was Ozempic (Semaglutide), with 920 prescriptions and refills. In total Kelsey J Barr wrote 6,131 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 920 | 1,339 | 172 | $1.3M |
| Jardiance Empagliflozin | 406 | 732 | 86 | $427K |
| Tresiba Flextouch U-200 Insulin Degludec | 394 | 861 | 117 | $517K |
| Levothyroxine Sodium Generic | 372 | 848 | 85 | $3,125 |
| Trulicity Dulaglutide | 340 | 476 | 75 | $465K |
| Farxiga Dapagliflozin Propanediol | 322 | 605 | 68 | $337K |
| Metformin Hcl Er Metformin Hcl | 241 | 501 | 65 | $1,990 |
| Metformin Hcl Generic | 224 | 526 | 62 | $1,736 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 217 | 380 | 56 | $31K |
| Mounjaro Tirzepatide | 206 | 261 | 33 | $269K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 189 | 460 | 78 | $21K |
| Humalog Kwikpen U-100 Insulin Lispro | 187 | 363 | 65 | $69K |
| Novolog Flexpen Insulin Aspart | 166 | 290 | 60 | $40K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 152 | 247 | 35 | $88K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 124 | 154 | 17 | $208K |
Brand drugs: 4,594 claims; generic drugs: 1,078 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelsey J Barr $1,456 ($1,456 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $314.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $314 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 24 | $232 |
| Novo Nordisk Inc NVO | 12 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $91.19 |
| Sequel Med Tech, LLC | 4 | $80.97 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $72.19 |
| Corcept Therapeutics CORT | 3 | $65.72 |
| Mallinckrodt Hospital Products Inc. | 3 | $65.07 |
| Radius Health, Inc. | 3 | $64.61 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $60.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.